Medtronic (XSWX:MDT) Forward Dividend Yield %: 3.53% (As of Jun. 25, 2026)


XSWX:MDT Medtronic PLC XSWX:MDT
21 GF Score
Price CHF65.29
GF Value CHF80.97
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Forward Dividend Yield %?

Medtronic XSWX:MDT +1.21% 21 Forward Dividend Yield % is 3.53% as of Jun. 25, 2026. GuruFocus rates XSWX:MDT with a GF Score™ of 21/100 and a GF Value™ of CHF80.97 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 316 Medical Devices & Instruments companies, Medtronic ranks better than 73.42% on this metric.

As of today (2026-06-25), the Forward Annual Dividend Yield of Medtronic is 3.53%.

As of today (2026-06-25), the Trailing Annual Dividend Yield of Medtronic is 0.86%.

XSWX:MDT's Forward Dividend Yield % is ranked better than
73.42% of 316 companies
in the Medical Devices & Instruments industry
Industry Median: 2.045 vs XSWX:MDT: 3.53

Medtronic's Dividends per Share for the three months ended in Apr. 2026 was CHF0.56.

During the past 12 months, Medtronic's average Dividends Per Share Growth Rate was 1.40% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 1.40% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 3.90% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 6.60% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Medtronic was 30.20% per year. The lowest was 1.40% per year. And the median was 15.40% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Medtronic  (XSWX:MDT) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Medtronic Forward Dividend Yield % Related Terms


XSWX:MDT vs SYK, BSX, EW: Forward Dividend Yield % Comparison

For the Medical Devices subindustry, Medtronic's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Medtronic's Forward Dividend Yield % falls into.


XSWX:MDT
21GF Score
Medtronic PLC XSWX:MDT
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Medtronic Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.7100002026-03-272026-03-272026-04-17Cash DividendquarterlyUSD:CHF 0.802700

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Medtronic's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=2.279668/65.29
=3.49 %

Current Share Price is CHF65.29.
Medtronic's Dividends per Share for the forward twelve months is calculated as CHF0.569917 * 4 = CHF2.279668.

Medtronic's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.569917/65.29
=0.87 %

Current Share Price is CHF65.29.
Medtronic's Dividends per Share for the trailing twelve months (TTM) ended in Today is CHF0.569917.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 3.53% mean?
Medtronic (XSWX:MDT) has a Forward Dividend Yield % of 3.53% as of Jun. 25, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Medtronic and its competitors. According to the industry distribution chart, Medtronic ranks #84 out of 316 companies in the Medical Devices & Instruments industry, placing it in the top 26.6%.
Is Medtronic's Forward Dividend Yield % too high?
Medtronic's current Forward Dividend Yield % is 3.53%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.05. Medtronic's value of 3.53% is 72.6% above this industry median. Based on the distribution chart, Medtronic ranks #84 out of 316 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medtronic has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Forward Dividend Yield % compare to SYK and BSX?
According to the Medical Devices & Instruments industry distribution chart, Medtronic ranks #84 out of 316 companies for Forward Dividend Yield %. This puts Medtronic in the upper half of its industry. The industry median Forward Dividend Yield % is 2.05. Medtronic's value of 3.53% is 72.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.05, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medtronic's current Forward Dividend Yield % of 3.53% is 72.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Medtronic and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medtronic's current Forward Dividend Yield % is 3.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (XSWX:MDT) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF80.97, compared to a current price of CHF65.29 — trading 19.4% below its estimated fair value. The current Forward Dividend Yield % is 3.53% and 72.6% above the Medical Devices & Instruments industry median of 2.05. Medtronic's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Medtronic (XSWX:MDT), the current Forward Dividend Yield % is 3.53% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (XSWX:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of CHF65.29 is trading 19.4% below its estimated GF Value™ of CHF80.97. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for XSWX:MDT:

  • Forward Dividend Yield %: 3.53%
  • GF Value™: CHF80.97 vs. price of CHF65.29 (19.4% below fair value)
  • GF Score™: 21/100 with 3 warning signs
  • Industry Position: 72.6% above the Medical Devices & Instruments median (#84 of 316)

No single metric tells the full story. See the XSWX:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
21GF Score

Get the complete analysis for XSWX:MDT

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF65.29
Price
CHF80.97
GF Value